Solvonis Therapeutics plc (LON:SVNS)
London flag London · Delayed Price · Currency is GBP · Price in GBX
0.2600
0.00 (0.00%)
At close: Feb 13, 2026

Solvonis Therapeutics Balance Sheet

Millions GBP. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2021
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 May '21
Cash & Equivalents
1.720.760.161.640.60.04
Cash & Short-Term Investments
1.720.760.161.640.60.04
Cash Growth
6266.67%388.39%-90.55%174.25%1433.33%56.00%
Accounts Receivable
0.12-0.070.040.020.04
Other Receivables
-0.040.020.060.120.04
Receivables
0.120.040.090.10.140.09
Inventory
--0.050.19--
Prepaid Expenses
-0.020.020.23--
Total Current Assets
1.830.820.312.160.740.13
Property, Plant & Equipment
--0.040.70.310.36
Other Intangible Assets
7.712.092.072.072.072.07
Other Long-Term Assets
00.30.010.010.010.01
Total Assets
9.553.22.434.943.132.57
Accounts Payable
1.550.080.160.190.840.42
Accrued Expenses
-0.040.090.140.520.22
Short-Term Debt
0.08---0.960.65
Current Portion of Leases
--0.010--
Current Unearned Revenue
--0.090.04--
Other Current Liabilities
0-0.03--0.03
Total Current Liabilities
1.630.120.390.372.321.32
Long-Term Leases
--0.020.02--
Total Liabilities
2.610.120.410.392.321.32
Common Stock
5.852.230.040.040.010.01
Additional Paid-In Capital
9.147.36770.940.94
Retained Earnings
-12.18-10.56-8.97-5.85-3.14-2.19
Comprehensive Income & Other
4.124.043.953.3632.48
Shareholders' Equity
6.943.082.034.550.811.25
Total Liabilities & Equity
9.553.22.434.943.132.57
Total Debt
0.08-0.030.020.960.65
Net Cash (Debt)
1.640.760.121.62-0.36-0.62
Net Cash Growth
-525.62%-92.52%---
Net Cash Per Share
0.000.000.000.02-0.01-0.01
Filing Date Shares Outstanding
5,9092,296124.76104.17069
Total Common Shares Outstanding
5,9092,296104.1104.17069
Working Capital
0.20.7-0.071.79-1.58-1.2
Book Value Per Share
0.000.000.020.040.010.02
Tangible Book Value
-0.781-0.042.49-1.26-0.82
Tangible Book Value Per Share
-0.000.00-0.000.02-0.02-0.01
Machinery
---0.940.540.55
Leasehold Improvements
---0.09--
Source: S&P Global Market Intelligence. Standard template. Financial Sources.